Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells-Reference-Cited by-同舟云学术

Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells

Published:2017-04-24 Issue:26 Volume:8 Page:43008-43022
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Haibo¹,Luo Dingyuan²,Zhang Lin³⁴,Lin Xiaofeng¹,Luo Qiuyun³,Yi Hanjie³,Wang Jing⁵,Yan Xianglei³,Li Baoxia³,Chen Yuelei⁶,Liu Xingguang¹,Zhang Hong¹,Liu Sheng¹,Qiu Miaozhen⁷,Yang Dajun³⁸,Jiang Ningyi¹

Affiliation:

1. Department of Nuclear Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China

2. Department of Vascular and Thyroid Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China

3. Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

4. Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

5. Department of Pharmacy, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China

6. The State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

7. Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510120, China

8. Suzhou Ascentage Pharma Inc., Jiangsu 215123, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitin-modifying enzymes in thyroid cancer：Mechanisms and functions;Heliyon;2024-07

2. Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesis;Biomedicine & Pharmacotherapy;2024-06

3. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15

4. Anticancer properties of spirooxindole derivatives;Spirooxindole;2024

5. Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials;Signal Transduction and Targeted Therapy;2023-09-06